Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen oral suspensions versus Nurofen in children with acute otitis media
2015-004077-32Phase 3
- Sponsor
- Berlin-Chemie AG
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ibuprofen in acute otitis media (AOM) (3 arms), sponsored by Berlin-Chemie AG. Primary endpoint: Pain relief proportion.
02
Drugs
ibuprofen
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on 2015-004077-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004077-32.